Trials / Completed
CompletedNCT01551875
A Study to Derive Normative Distribution of CIMT and to Determine Its Correlation With Cardiovascular Risk Factors
A Study to Derive Normative Distribution of CIMT and to Determine Its Correlation With Cardiovascular Risk Factors in Asymptomatic Nationwide Indian Population (SCORE India)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Accepted
Summary
This non-interventional, prospective, multi-centric, cross-sectional study is aimed to obtain the distribution of measurements of CIMT in Indian subjects and will involve approx. 30 investigative sites from all over the country. Each investigative site will be expected to enrol 50 subjects and Carotid intima-media thickness (CIMT) values will be taken for each individual as described in the protocol. All the procedures could be completed in a single day, however due to any reason any study variable is not taken subject may be asked to come back for a second visit within 7 days of the first visit.
Detailed description
A Study to derive normative distribution of CIMT and to determine its cOrrelation with cardiovascular Risk factors in asymptomatic nationwidE Indian population. (SCORE India)
Conditions
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2012-03-13
- Last updated
- 2013-07-09
Locations
24 sites across 1 country: India
Source: ClinicalTrials.gov record NCT01551875. Inclusion in this directory is not an endorsement.